BlossomHill Therapeutics
SAN DIEGO, CA · Founded 2020 · CIK 0001839970 · Biotech · Public
Therapeutic drugs for human disease
bhtherapeutics.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $246M
- 4 Form D · Dec 2025
- 10 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 40
- 0 granted · 40 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2020202120222023202420252026
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $2,000,000 | |
| Private capital raised | Form D · SEC | $70,999,993 | |
| Private capital raised | Form D · SEC | $88,649,917 | |
| Private capital raised | Form D · SEC | $84,152,909 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 3377 | Inspira Therapeutics, Inc | — | — |
| 3378 | SYGNAMAP, INC. | — | — |
| 3379 | Polyrizon Ltd. | — | $7.5M |
| 3380 | BlossomHill Therapeutics | — | $246M |
| 3381 | Shattuck Labs, Inc. | — | $164M |
| 3382 | Colossal Biosciences | — | $150M |
| 3383 | PepGen Inc. | — | $127M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Sundeep AgrawalDirector
- SUNDEEP AGRAWALDirector
- Bihua ChenDirector
- BIHUA CHENDirector
- Carl GordonDirector
- CARL GORDONDirector
- Jingrong Jean CuiDirector · Executive Officer
- JINGRONG JEAN CUIDirector · Executive Officer
- George LeeDirector
- GEORGE LEEDirector
- Yishan LiDirector · Executive Officer
- YISHAN LIDirector · Executive Officer
- Hongbo LuDirector
- TIMOTHY STUBBSDirector
- Li YishanDirector · Executive Officer
Patents
- Indazole Macrocycles And Their Useapplication
- Fused Ring Kras Inhibitors For Treating Diseaseapplication
- Indazole Containing Macrocycles And Their Useapplication
- Macrocyclic Compounds And Use As Kinase Inhibitorsapplication
- Macrocycles And Their Useapplication
- Macrocycles And Their Useapplication
- Azaindazole Macrocycle Solid Formsapplication
- Azaindazole Macrocycle Solid Formsapplication
- Egfr Inhibitors For Treating Diseaseapplication
- Azaindazole Macrocycle Solid Formsapplication
- Bis-bicycloheteroaryl Macrocycles And Their Useapplication
- Macrocyclic Compounds And Their Useapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.